98%
921
2 minutes
20
Backgrounds/aims: Reconstruction of hepatic venous outflow is crucial in living donor liver transplantation (LDLT) to prevent graft congestion. This study evaluated the feasibility, long-term patency, complications, and survival rates of single-orifice hepatic venous outflow reconstruction using right lobe grafts.
Methods: A prospective study was conducted involving 52 patients who underwent LDLT with right lobe grafts at 108 Military Central Hospital, Vietnam, from January 2019 to December 2020, with follow-up extending until December 2024. The technique included forming a single triangular orifice by joining the middle hepatic vein (MHV) and right hepatic vein, utilizing extended right lobe grafts with the MHV or modified right lobe grafts where MHV reconstruction was performed using polytetrafluoroethylene grafts. Outcome measures included ultrasound, CT scans, and regular clinical follow-up.
Results: Ten patients (19.3%) required MHV reconstruction. Mean reconstruction time was 17.4 minutes; cold ischemic time averaged 40.9 ± 6.3 minutes. Intraoperative patency was achieved in all cases, with 96.2% showing complete graft perfusion. Five-year patency was 94.2%. MHV complications occurred in three patients (5.8%): two stenoses (3.8%, conservatively managed) and one fatal occlusion (1.9%). Anastomotic diameter ≤ 30 mm significantly increased complication risk (odds ratio [OR] 14.286; 95% confidence interval [CI]: 1.121-183.823; = 0.011). Five-year survival was 84.6% (95% CI: 75.2%-93.9%), with rates of 100% for cirrhosis, 85.7% for hepatocellular carcinoma, and 58.8% for acute-on-chronic liver failure.
Conclusions: Single-orifice hepatic venous outflow reconstruction is simple, efficient, and reliable in LDLT, achieving high long-term patency and low complication rates without cadaveric grafts.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.14701/ahbps.25-109 | DOI Listing |
BMJ Open
September 2025
Department of Interventional Radiology, The First Hospital of China Medical University, Shenyang, Liaoning, China
Background: Advanced-stage hepatocellular carcinoma (HCC) with high tumour burden and portal vein tumour thrombus (PVTT) is usually associated with poor survival outcomes. Rapid tumour control usually benefits long-term outcomes, which could be hardly achieved by solely systematic targeted and immunotherapy in current guidelines. Hepatic arterial infusion chemotherapy (HAIC) is reported as an effective intervention for rapid decrease of tumour burden.
View Article and Find Full Text PDFJ Thorac Cardiovasc Surg
September 2025
Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota. Electronic address:
Introduction: Goals of left ventricular assist device (LVAD) therapy includes low rates of right ventricular failure (RVF) and favorable survival outcomes. However, conventional metrics often fail to capture its physiologic complexity. We evaluated the prognostic utility of the Active Cardiac Index (ActCI) and Passive Cardiac Index (PasCI)-which reflect cardiac output driven by active RV contractility and passive venous return, respectively.
View Article and Find Full Text PDFBMC Pediatr
September 2025
Pediatric Surgery Department, Faculty of Medicine, Minia University, Minia, Egypt.
Aim Of The Study: To present a case series of four pediatric patients with PDPV, each with a different clinical presentation and surgical management.
Methods: We retrospectively reviewed four cases of PDPV managed at our institution. Two cases were associated with extrahepatic biliary atresia (EHBA) and discovered incidentally during surgery.
Ann Surg Oncol
September 2025
Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Background: Hepatocellular carcinoma (HCC) frequently invades the portal vein, leading to early recurrence and a poor prognosis. However, the mechanisms underlying this invasion remain unclear. In this study, we aimed to detect portal vein circulating tumor cells (CTCs) using a Glypican-3-positive detection method and evaluate their prognostic significance.
View Article and Find Full Text PDFWorld J Urol
September 2025
Department of Urology and Transplantation Surgery, Nantes University Hospital, Nantes, France.
Purpose: In 5-10% of cases, renal cancer extends into the venous system, particularly the inferior vena cava (IVC), which worsens prognosis. This study aims to assess morbidity, mortality, and oncological outcomes of patients treated surgically for renal cancer with IVC extension over a 30-year period, in two experienced centers.
Materials And Methods: This bicentric, retrospective study analyzed patients treated between 1988 and 2020 for renal cancer involving the IVC.